- 24 biweekly issues of business strategies and analysis for health plans, employers, PBMs and pharmaceutical companies, delivered by First Class U.S. Mail and electronically,
- Access to a subscriber-only Web page with:
- Searchable archives of past articles,
- Convenient library with PDFs of back issues,
- Recent stories of interest grouped for convenient reading, and
- Regular postings from your editor.
Subscription Required
Only paid subscribers to Radar on Drug Benefits can access this Web portal with three years of back issues, searchable article archives and other valuable resources.
Subscribers to Radar on Drug Benefits receive
Recent Stories
From Radar on Drug Benefits - The CEO of Harvard Pilgrim Health Care recently posited that Narcan (naloxone), an opiate antidote, should be as readily available as fire extinguishers or defibrillators in the workplace. As health insurers seek ways to address the U.S. opioid crisis, the Trump administration is putting significant weight on the regulatory side. CMS on April 2 finalized new policies in its 2019 Rate Announcement and Final Call Letter for Medicare Advantage (MA) and Part D plans that continue to focus heavily on ways to monitor and decrease opioid misuse. Read more
From the Editor
It's quick and easy to sign up for FREE access to AISHealth.com!